Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 randomized trial of droxidopa for fatigue in Parkinson's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Parkinson Disease

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

Sponsor: The Cooper Health System | Conditions: Parkinson Disease, Fatigue | Phase 4 | Status: TERMINATED